author-photo

Ellen Scheers

Janssen Pharmaceutica

8

Papers

179

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Prediction of the drug–drug interaction potential of the α1-acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib

2021
Show All
- Source
- Cite
- Save
Citations (0)
Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor.

2020 Xenobiotica
Show All
- Source
- Cite
- Save
Citations (2)
In vitro and physiologically‐based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin

2017 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (12)
THE IMPORTANCE OF DOSE- AND TIME-DEPENDENT PHARMACOKINETICS DURING EARLY METABOLITE SAFETY ASSESSMENT IN HUMANS

2016
Show All
- Source
- Cite
- Save
Citations (0)
Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants

2015 Clinical pharmacology in drug development
Show All
- Source
- Cite
- Save
Citations (18)
Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans

2014 Drug Metabolism and Disposition
Show All
- Source
- Cite
- Save
Citations (40)
Absorption, Metabolism and Excretion of Oral 14C Radiolabeled Ibrutinib: An Open-label, Phase I, Single-dose Study in Healthy Men

2014 Drug Metabolism and Disposition
Show All
- Source
- Cite
- Save
Citations (84)